Referenser till artikeln "Integrativ medicin mot epilepsi"

Adler, Jerry. ”In the Grip of the Unknown”. 2009-04-10. The Daily Beast. http://www.thedailybeast.com/newsweek/2009/04/10/in-the-grip-of-the-unknown.html
Andrews, Donna och Reiter, Joel. ”Comprehensive Neurobehavioral Approach”. I: (red.) Devinsky, Orrin; Pacia, Steven; Schachter, Steven. Alternative Therapies for Epilepsy. 2005, Demos Medical Publishing.
Devinsky, Orrin; Pacia, Steven; Schachter, Steven. Complementary and Alternative Therapies for Epilepsy. 2012, Demos Medical Publishing. Bennett, Chris. “Early/Ancient History”. I: (red.) Holland, Julie. The Pot Book. A Complete Guide to
Cannabis. 2010, Park Street Press. Klein, Amy. ”Fighting Epilepsy”. BrainWorld Newsletter. http://brainworldmagazine.com/fighting-
epilepsy. Romney, Lee. ”On the frontier of medical pot to treat boy's epilepsy”. Los Angeles Times 2012-09-13
Referenser
1) Soman S, Korah PK, Jayanarayanan S et al. ”Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A”. Neurochem Res. 2012 Sep;37(9):1915-27. 2) Singh B, Singh D, Goel RK. ”Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression”. J Ethnopharmacol. 2012 Jan 6;139(1):273-9.
3) Rodriguez-Sainz A, Pinedo-Brochado A, Sánchez-Menoyo JL et al. ”Migraine, Stroke and Epilepsy: Underlying and Interrelated Causes, Diagnosis and Treatment”. Curr Treat Options Cardiovasc Med. 2013 Feb 17. 4) Winawer MR, Connors R; EPGP Investigators. ”Evidence for a shared genetic susceptibility to migraine and epilepsy”. Epilepsia. 2013 Feb;54(2):288-95.
5) Fernández-Ruiz J, Sagredo O, Pazos MR et al. ”Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?” Br J Clin Pharmacol. 2013 Feb;75(2):323-333. 6) Jones NA, Glyn SE, Akiyama S et al. ”Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures”. Seizure. 2012 Jun;21(5):344-52.
7) Hill AJ, Williams CM, Whalley BJ, Stephens GJ. ”Phytocannabinoids as novel therapeutic agents in CNS disorders.” Pharmacol Ther. 2012 Jan;133(1):79-97. 8) Nagarkatti P, Pandey R, Rieder SA. ”Cannabinoids as novel anti-inflammatory drugs”. Future Med Chem. 2009 October; 1(7): 1333–1349.
9) CBD Science. ”Guide to Medical Marijuana”. 2012. http://www.cbdscience.com/files/51746015.pdf Hämtad 2013-03-11. 10) Hegde M, Santos-Sanchez C, Hess CP, Kabir AA, Garcia PA. ”Seizure exacerbation in two patients with focal epilepsy following marijuana cessation”. Epilepsy Behav. 2012 Dec;25(4):563-6 11) Hofmann ME, Frazier CJ. ”Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention”. Exp Neurol. 2011 Dec 9. 12) Mortati K, Dworetzky B, Devinsky O. ”Marijuana: an effective antiepileptic treatment in partial epilepsy? A case report and review of the literature”. Rev Neurol Dis. 2007 Spring;4(2):103-6. 13) Lapoint J, James LP, Moran CL et al. ”Severe toxicity following synthetic cannabinoid ingestion”. Clin Toxicol (Phila). 2011 Oct;49(8):760-4.
Jaydens extrakt: Healing Tincture – http://www.4altacalifornia.com/about.html